NCT03499015

Brief Summary

Otitis media with effusion (OME) is very common in children and characterized by fluid in the middle ear without signs or symptoms of acute ear infection. Treatment options are tympanostomy tubes and/or adenoidectomy. However OME often reoccurs after these procedures. Goal of this study will be to evaluate the Balloon Eustachian Tuboplasty (BET) in children as an additional treatment option and to assess long-term effects of BET. Beside the standard procedure, children (4 to 10 years of age), with equal pathology on both ears, will be assigned for BET on side.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 25, 2018

Completed
23 days until next milestone

First Posted

Study publicly available on registry

April 17, 2018

Completed
8 months until next milestone

Study Start

First participant enrolled

December 14, 2018

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2020

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2020

Completed
Last Updated

November 14, 2018

Status Verified

November 1, 2018

Enrollment Period

1.2 years

First QC Date

March 25, 2018

Last Update Submit

November 11, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Tympanometry-Change (Middle ear effusion/eardrum mobility assessed with Tympanometry)

    Tympanometry, an objective test of middle-ear function, uses variations of air pressure in the ear canal to assess for middle ear effusion / eardrum mobility.

    up to 3 months preoperatively and change to 3, 6 and 9 months postoperatively;

Secondary Outcomes (1)

  • Otoscopy score

    up to 3 months preoperatively and change to 3, 6 and 9 months postoperatively;

Other Outcomes (1)

  • symptom-based side depended questionnaire

    preoperatively and 9 months postoperatively

Study Arms (2)

Ear without BET

NO INTERVENTION

ear without BET treatment works as control

BET ear

EXPERIMENTAL

ear with BET treatment works as intervention arm

Procedure: Balloon Eustachian Tuboplasty (BET)

Interventions

A balloon catheter is used to dilate the cartilage part of the eustachian tube and is inserted through the nose to reach the opening of the tube, located in the nasopharynx.

BET ear

Eligibility Criteria

Age4 Years - 10 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • OME on both sides measured by flat tympanometry

You may not qualify if:

  • Patients with cleft lip and/or palate and other severe craniofacial abnormalities

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical university of Vienna

Vienna, 1090, Austria

RECRUITING

Related Publications (7)

  • Rosenfeld RM, Shin JJ, Schwartz SR, Coggins R, Gagnon L, Hackell JM, Hoelting D, Hunter LL, Kummer AW, Payne SC, Poe DS, Veling M, Vila PM, Walsh SA, Corrigan MD. Clinical Practice Guideline: Otitis Media with Effusion Executive Summary (Update). Otolaryngol Head Neck Surg. 2016 Feb;154(2):201-14. doi: 10.1177/0194599815624407.

    PMID: 26833645BACKGROUND
  • Maier S, Tisch M, Maier H. [Balloon dilation of the Eustachian tube in pediatric chronic obstructive Eustachian tube dysfunction patients]. HNO. 2015 Oct;63(10):686-8, 690-4, 696-7. doi: 10.1007/s00106-015-0050-5. German.

    PMID: 26311130BACKGROUND
  • Tisch M, Maier S, Hecht P, Maier H. [Bilateral Eustachian tube dilation in infants: an alternative treatment for persistent middle ear functional dysfunction]. HNO. 2013 Jun;61(6):492-3. doi: 10.1007/s00106-013-2713-4. German.

    PMID: 23712367BACKGROUND
  • Popova D, Varbanova S, Popov TM. Comparison between myringotomy and tympanostomy tubes in combination with adenoidectomy in 3-7-year-old children with otitis media with effusion. Int J Pediatr Otorhinolaryngol. 2010 Jul;74(7):777-80. doi: 10.1016/j.ijporl.2010.03.054.

    PMID: 20399511BACKGROUND
  • Jenckel F, Kappo N, Gliese A, Loewenthal M, Lorincz BB, Knecht R, Dalchow CV. Endonasal dilatation of the Eustachian tube (EET) in children: feasibility and the role of tubomanometry (Esteve) in outcomes measurement. Eur Arch Otorhinolaryngol. 2015 Dec;272(12):3677-83. doi: 10.1007/s00405-014-3443-2. Epub 2014 Dec 19.

    PMID: 25524643BACKGROUND
  • Van Roeyen S, Van de Heyning P, Van Rompaey V. Delayed-Start Study Design for Balloon Dilation of the Eustachian Tube: Alternative for a Randomized Controlled Trial. Front Surg. 2017 Feb 20;4:10. doi: 10.3389/fsurg.2017.00010. eCollection 2017. No abstract available.

    PMID: 28265561BACKGROUND
  • Poe D, Anand V, Dean M, Roberts WH, Stolovitzky JP, Hoffmann K, Nachlas NE, Light JP, Widick MH, Sugrue JP, Elliott CL, Rosenberg SI, Guillory P, Brown N, Syms CA 3rd, Hilton CW, McElveen JT Jr, Singh A, Weiss RL Jr, Arriaga MA, Leopold JP. Balloon dilation of the eustachian tube for dilatory dysfunction: A randomized controlled trial. Laryngoscope. 2018 May;128(5):1200-1206. doi: 10.1002/lary.26827. Epub 2017 Sep 20.

    PMID: 28940574BACKGROUND

MeSH Terms

Conditions

Otitis Media with Effusion

Condition Hierarchy (Ancestors)

Otitis MediaOtitisEar DiseasesOtorhinolaryngologic Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
only surgeon knows treated side, documentation of side only visible to surgeon and investigator
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: single-sided treatment, contralateral side with same pathology works as control
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assoc. Prof. PD M.D.

Study Record Dates

First Submitted

March 25, 2018

First Posted

April 17, 2018

Study Start

December 14, 2018

Primary Completion

March 1, 2020

Study Completion

October 1, 2020

Last Updated

November 14, 2018

Record last verified: 2018-11

Data Sharing

IPD Sharing
Will not share

Locations